BRD2 and polycystic ovary syndrome: AMH has been proposed as an effective endocrine factor in the pathophysiology of PCOS, considering its elevated serum level in PCOS, its overproduction by granulosa cells in anovulatory PCOS, its cross-communication with luteinizing hormone (LH) and follicle-stimulating hormone (FSH) leading to HA, and finally, its correlation with the severity of ovulatory dysfunction and PCOS [28, 31].